Table 2.

Clinical information from the eligible trials in the meta-analysis.

Included studies	Dosage of TSF	Intervention period	Intervening methods	Control group regimens	Parameter types	Reference
Wang T 2013	8 grams TSF, twice daily	24 weeks	TSF VS Con	placebo	glycosylated hemoglobin (HbA1c),24-hour total urine protein (24-hTP)	(19)
Yang H 2024	8 grams TSF, twice daily	24 weeks	TSF VS Con	placebo	hemoglobin A1c (HbA1c), albumin-to-creatinine ratio (UACR) levels,8-hydroxy-2′-deoxyguanosine (8-OHdG), 3-nitrotyrosine (3-NT), the enzymic anti-oxidant, superoxide dismutase (SOD)	(20)
Yang X 2016	8 grams TSF, twice daily	24 weeks	TSF VS Con	placebo	Scr (μmol/L),24 h UP (g/24 h),eGFR (ml/min/1.73 m2), In plasma L-FABP (μg/ml)	(21)
Li P 2015	8 grams TSF, twice daily	24 weeks	TSF VS Con	placebo	ORR,AE,UAER (μg/min),Scr (μmol/L),24 h UP (g/24 h),eGFR (ml/min/1.73 m2),BUN (mmol/L)	(22)

Scr (μmol/L), Serum Creatinine; 24 h UP (g/24 h), 24-Hour Urine Protein; eGFR, Estimated Glomerular Filtration Rate; ORR, Objective Response Rate; AE, Adverse Event; UAER, Urine Albumin Excretion Rate; BUN, Blood Urea Nitrogen; L-FABP, Liver Fatty Acid Binding Protein.

Meta-analyses of Chinese herbal medicine Formula treatment with diabetic kidney disease.